LDLR and metabolic dysfunction-associated steatohepatitis: In the liver, neutrophil-specific microRNA-223 (miR-223) internalizes into hepatocytes through the expression of LDLR, thereby inhibiting the expression of hepatitis and fibrosis genes and improving nonalcoholic steatohepatitis [61].